Stromal Extracellular Matrix Components As Growth Regulators For Human Hematopoietic Progenitors

References

• Shofield, R. (1978). The relationship between the spleen colony-forming cell and the hematopoietic stem cell: a hypothesis, Blood Cells, 4, 7–25.
   PubMedGoogle Scholar
• Yoder, M. C. and Williams, D. A. (1995). Matrix molecule interactions with hematopoietic stem cells, Experimental Hematology, 23, 961–7.
   PubMed Web of Science ®Google Scholar
• Dexter, T. M., Coutinho, L. H., Spooncer, E., Heyworth, C. M., Daniel, C. P., Schiro, R., Chang, J. and Allen, T. D. (1990). Stromal cells in haemopoiesis. In: Molecular control of haemopoiesis. Wiley, Chichester, [Ciba Found Symp 148] 76–95.
   Google Scholar
• Cashman, J. D., Eaves, A. C., Raines, E. W., Ross, R. and Eaves, C. J. (1990). Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β, Blood, 75, 96–101.
   PubMed Web of Science ®Google Scholar
• Coloumbel, L., Eaves, A. C. and Eaves, C. J. (1983). Enzymatic treatment of long-term marrow cultures reveals the preferential location of primitive hematopoietic progenitors in the adherent layer, Blood, 62, 291–299.
   PubMed Web of Science ®Google Scholar
• Fraser, C., Szilvassy, S., Eaves, C. and Humphries, R. (1992). Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability, Proc Natl Acad Sci USA, 89, 1968–1972.
   PubMed Web of Science ®Google Scholar
• Barnett, M. J., Eaves, C. J., Philips, G. L., Kalousek, K. D., Klingeman, H. G., Landsdorp, P. M., Reece, D. E., Sheperd, J. D., Shaw, G. J. and Eaves, A. C. (1989). Successful autografting in chronic myelogenous leukemia after maintenance of marrow in culture, Bone Marrow Transpl, 4, 345.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M. (1992). Direct contact between human primitive hematopoietic progenitors and marrow stroma is not required for long-term in vitro hematopoiesis, Blood, 79, 2821–2826.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M. (1993). Soluble factor(s) produced by human marrow stroma increase cytokine induces proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation, Blood, 82, 2045–2054.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M. MIP-1α combined with IL3 maintains primitive human LTBMC-IC for at least 8 weeks in ex vivo stroma-non-contact cultures, J. Exp. Med.
   Google Scholar
• Verfaillie, C. and Miller, J. (1994). CD34 +/CD33—cells reselected from stroma-non-contact cultures contain more than 20 percent primitive progenitors capable of long-term in vitro hematopoiesis, Blood.
   Google Scholar
• Sutherland, H. J., Eaves, C. J., Landsdorp, P. M, Thaker, J. D. and Hogge, D. E. (1991). Differential regulation of primitive human hematopoietic cells in long-term marrow cultures maintained on genetically engineered murine stromal cells, Blood, 78, 666–672.
   PubMed Web of Science ®Google Scholar
• Burrhoughs, J. M., Gupta, P. and Verfaillie, C. M. (1994). Soluble factors from the mouse fibroblast cell line M210-B4 support in vitro hematopoiesis, Exp. Hematol., 22, 095–1101.
   PubMedGoogle Scholar
• Bathia, R., Dewald, G., McGlave, P. and Verfaillie, C. M. (1995). Abnormalities of the bone marrow microenvironment in chronic myelogenous leukemia are related to maliganant macrophages, Blood, 85, 3636–3645.
   PubMed Web of Science ®Google Scholar
• Gupta, P., McCarthy, J. B. and Verfaillie, C. M. (1996). Marrow Stroma Derived Proteoglycans Combined With Physiological Concentrations Of Cytokines Are Required For LTC-IC Maintenance, Blood, 87, 3229–3236.
   PubMed Web of Science ®Google Scholar
• Templeton, D. M. (1992). Proteoglycans in cell regulation, Crit Rev Clin Lab Sci, 29, 141–184.
   PubMed Web of Science ®Google Scholar
• Ruoslahti, E., Yamaguchi, Y., Hildegrand, A. and Border, W. A. (1992). Extracellular matrix/growth factor interactions, Cold Springs Harbor Symposia on Quantitative Biology, 57, 309–315.
   PubMedGoogle Scholar
• Burgess, W. H. and Maciag, T. (1989). The heparin-binding (fibroblast) growth factor family of proteins, Annu Rev Biochem, 58, 575.
   PubMed Web of Science ®Google Scholar
• Ishai-Michaeli, R., Eldor, A. and Vlodavsky, I. (1990). Heraranase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix, Cell Reg, 1, 833.
   PubMedGoogle Scholar
• Gordon, M. Y., Riley, G. P., Watt, S. M. and Greaves, M. F. (1987). Compartmentalization of a haematopoietic growth factor [GM-CSF] by glycosaminoglycans in the bone marrow microenvironment, Nature, 326, 403–405.
   PubMed Web of Science ®Google Scholar
• Roberts, R., Gallagher, J., Spooncer, E., Allen, T. D., Bloomfield, F. and Dexter, T. M. (1988). Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis, Nature, 332, 376–378.
   PubMed Web of Science ®Google Scholar
• Perin, J.-P., Bonnet, F., Maillet, P. and Jolles, P. (1988). Characterization and N-terminal sequence of human platelet factor proteoglycan, Biochem J, 255, 1007.
   PubMed Web of Science ®Google Scholar
• Wright, T. N., Kinsella, M. G., Keating, A. and Singer, J. W. (1986). Proteoglycans in human long-term marrow cultures: biochemical and ultrastructural analyses, Blood, 67, 1333–1343.
   PubMed Web of Science ®Google Scholar
• Gallagher, J. T., Spooncer, E. and Dexter, T. M. (1983). Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse marrow cell cultures, J. Cell. Sci, 63, 155–171.
   PubMed Web of Science ®Google Scholar
• Gordon, M. Y., Dowdling, C. R., Riley, G. P., Goldman, J. M. and Greaves, M. F. (1984). Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukaemia, Nature, 328, 342–344.
   Web of Science ®Google Scholar
• Gordon, M. Y., Riley, G. P. and Clarke, D. (1988). Heparan-sulfate is necessary for adhesive interactions between human early hemopoietic progenitors cells and the extracellular matrix of the marrow microenvironment, Leukemia, 2, 804–809.
   PubMed Web of Science ®Google Scholar
• Siczkowski, M., Clarke, D. and Gordon, M. Y. (1992). Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan-sulfate, Blood, 80, 912–919.
   PubMed Web of Science ®Google Scholar
• Spooncer, E., Gallagher, J. T., Krizsa, F. and Dexter, T. M. (1988). Regulation of haemopoiesis in longterm marrow cultures. IV. Glycosaminoglycan synthesis and the stimulation of haemopoiesis by β-D-xylosides, J Cell. Biol, 96, 510–514.
   Web of Science ®Google Scholar
• Luikart, S. D., Maniglia, C. A., Furcht, J. T., McCarthy, J. B. and Oegema Jr, T. R. (1990). A heparan-sulfate-containing fraction of marrow stroma induces maturation of HL-60 cells, in vitro, Cancer Res, 50, 3781–3785.
   PubMed Web of Science ®Google Scholar
• Tanaka, Y., Adams, D. H., Hunsher, S., Hirano, H., Siebenlist, U. and Shaw, S. (1993). T-cell adhesion induced by proteoglycan immobilized cytokine MI P-1β, Nature, 361, 79–82.
   PubMed Web of Science ®Google Scholar
• Hurley, R. W., McCarthy, J. B. and Verfaillie, C. M. (1995). Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation, J. Clin.lnvest, 96, 511–519.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C., Blakolmer, K. and McGlave, P. (1990). Purified primitive hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma, J. Exp. Med, 172, 509–520.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M., McCarthy, J. B. and McGlave, P. B. (1991). Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin, J. Exp. Med, 174, 693–703.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M., Benis, A., Iida, G., McGlave, P. B. and McCarthy, J. (1994). Adhesion of committed human hematopoietic progenitors to synthetic peptides in the C-terminal heparin-binding domain of fibronectin: Cooperation between the integrin α4β1 and the CD44 adhesion receptor, Blood, 84, 1802–1812.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M., McCarthy, J. B. and McGlave, P. B. (1992). Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV, J. Clin. Invest, 90, 1232–1241.
   PubMed Web of Science ®Google Scholar
• Simmons, P. J., Masinovsky, B., Longenecker, B. M., Berenson, R., Torok-Storb, B. and Gallatin, W. M. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells, Blood, 80, 388–395.
   PubMed Web of Science ®Google Scholar
• Teixidó, J., Hemler, M. E., Greenberger, J. S. and Anklesaria, P. (1992). Role of β1 and β2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma, J. Clin. Invest, 90, 358–367.
   PubMed Web of Science ®Google Scholar
• Kerst, J. M., Sanders, J. B., Slaper-Cortenbach, I. C. M., Doorakkers, M. C., Hooibrink, B., van Oers, R. H. J., von dem Borne, A. E. G. K. and van der Schoot, C. E. (1993). α4β1 and α5β1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way, Blood, 81, 344–351.
   PubMed Web of Science ®Google Scholar
• Hurley, R., McCarthy, J. B. and Verfaillie, C. M. (1996). Clustering Of Integrins Results In Proliferation Inhibition Of Committed Hematopoietic Progenitors Through Mechanisms Involving The Cell Cytoskeleton, Experimental Hematology, Exp. Hematology In Press.
   Google Scholar
• Albelda, S. M. and Buck, C. A. (1990). Integrins and other cell adhesion molecules, FASEB J, 4, 2868–2880.
   PubMed Web of Science ®Google Scholar
• Hemler, M. E., Huang, C. and Schwarz, L. (1987). The VLA protein family, J. Biol. Chem, 262, 3300–3309.
   PubMed Web of Science ®Google Scholar
• Pavalko, F. M. and Otey, C. A. (1994). Role of the adhesion molecule cytoplasmatic domains in mediating interactions with the cytoskeleton, Proc Soc Exp Biol Med, 205, 282.
   PubMed Web of Science ®Google Scholar
• Clark, E. A. and Brugge. J. S. (1995). Integrins and signal transduction pathways: The road taken. Science, 268, 233–239.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., Akiyama, S. K. and Yamada, K. M. (1995). Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function, Science, 267, 883–5.
   PubMed Web of Science ®Google Scholar
• Chen, H. C., Appeddu, P. A., Parsons, J. T., Hildebrand, J. D., Schaller, M. D. and Guan, J. L. (1995). Interaction of focal adhesion kinase with cytoskeletal protein talin, J. Biol. Chem, 270, 16995–9.
   PubMed Web of Science ®Google Scholar
• Kornberg, L. T., Earp, H. S., Turner, C. E., Prockop, C. and Juliano, R. L. (1992). Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins, Proc. Natl. Acad. Sci, USA, 157, 105–132.
   Google Scholar
• Guan, J.-L. and Trevithick, J. E., (1991). Hynes RO Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein, Cell Regulation, 2, 951–964.
   PubMedGoogle Scholar
• Burridge, K., Turner, C. E. and Romer, L. H. (1992). Tyrosine phosphorylation of paxillin and p125 FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly, J. Cell Biol, 119, 893–903.
   PubMed Web of Science ®Google Scholar
• Calalb, M. B., Polte, T. R. and Hanks, S. K. (1995). Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. & Cell, Biology, 15, 954–63.
   Web of Science ®Google Scholar
• Bellis, S. L. Miller, J. T. and Turner, C. E. (1995). Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase, J. Biol. Chem, 270, 17437–17441.
   PubMed Web of Science ®Google Scholar
• Schaller, M. D. and Parsons, J. T. (1995). Pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk, Mol & Cell Biol, 15, 2635–45.
   Web of Science ®Google Scholar
• Schlaepfer, D. D. Hanks, S. K. Hunter, T. and van der Geer, P. (1994). Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase, Nature, 372, 786–789.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., Saleem, A., Yuan, Z., Emoto, Y., Prasad, K. V. and Kufe, D. (1995). Stimulation of human monocytes with macrophage colony-stimulating factor induces a Grb2-mediated association of the focal adhesion kinase pp125FAK and dynamin, Proc. Natl. Acad. Sci. USA, 92, 6132–6136.
   PubMed Web of Science ®Google Scholar
• Saxton, T. M., van Oostveen, I., Bowtell, D., Aebersold, R. and Gold, M. R. (1994). B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2. mSOS1. and a 145-kDa tyrosine-phosphorylated protein, J. of Imm, 153, 623–36.
   PubMed Web of Science ®Google Scholar
• Teng, K. K., Lander, H., Fajardo, J. E., Hanafusa, H., Hempstead, B. L. and Birge, R. B. (1995). v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway, J. Biol. Chem, 270, 20677–85.
   PubMed Web of Science ®Google Scholar
• Yurochko, A. D., Liu, D. Y., Eierman, D. and Haskill, S. (1992). Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction, Proc. Natl. Acad. Sci, USA, 89, 9034–9038.
   PubMed Web of Science ®Google Scholar
• Shaw, R. J., Doherty, D. E., Ritter, A. G., Benedict, S. H. and Clark, R. A. F. (1990). Adherence dependent increase in human monocyte PDGF(B) mRNA is associated with increases in c-fos, c-jun and EGR2 mRNA, J Cell Biol, 111, 2139.
   PubMed Web of Science ®Google Scholar
• Guadagno, T. M., Ohtsubo, M., Roberts, J. M. and Assosian, R. K. (1993). A link between cyclin A expression and adhesion-dependent cell cycle progression, Science, 262, 1572–5.
   PubMed Web of Science ®Google Scholar
• Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G. and Cheresh, D. A. (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell, 79, 1157–64.
   PubMed Web of Science ®Google Scholar
• Davis, L. S., Oppenheimer-Marks, N., Bednarczyk, J. L., McIntyre, B. W. and Lipsky, P. E. (1990). Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules, J. Immunol, 145, 785–793.
   PubMed Web of Science ®Google Scholar
• Dike, L. E. and Farmer, S. E. (1988). Cell adhesion induces expression of growth-associated genes in suspension arrested fibroblasts, Proc. Natl. Acad. Sci, USA, 85, 6792–6797.
   PubMed Web of Science ®Google Scholar
• Rowley, J. D. (1990). The Philadelphia chromosome translocation: A paradigm for understanding leukemia, Cancer, 65, 2178.
   PubMed Web of Science ®Google Scholar
• Bartram, C. R., deKlein, A., Hagemeijer, A., van Agthoven, T., Geurts van Kessel, A., Bootsma, D., Grosveld, G., Ferguson-Smith, M. A., Davies, T. and Stone, M. (1983). Translocation of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia, Nature, 306, 277–80.
   PubMed Web of Science ®Google Scholar
• Kantarjian, H. M., Smith, T. L., McCredie, K. B., Keating, M. J., Walters, R. S., Talpaz, M., Hester, J. P., Bligham, G., Gehan, E. and Freireich, E. J. (1985). Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival, Blood, 66, 1326–1335.
   PubMed Web of Science ®Google Scholar
• Daley, G. Q., Van Etten, R. A. and Baltimore, D. (1990). Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome, Science, 247, 824–829.
   PubMed Web of Science ®Google Scholar
• Gishizky, M. L. and Witte, O. N. (1992). Initiation of dysregulated growth of multipotent progenitor cells by bcr-abl in vitro, Science, 256, 836–839.
   PubMed Web of Science ®Google Scholar
• Bhatia, R., Wayner, E., McGlave, P. and Verfaillie, C. M. (1994). Interferon-α restores adhesion of malignant progenitors in CML by restoring β1 integrin function, J. Clin. Invest, 94, 384–391.
   PubMed Web of Science ®Google Scholar
• Bhatia, R., McGlave, P. B. and Verfaillie, C. M. (1995). Interferon-α treatment of normal bone marrow stroma results in enhanced adhesion of CML hematopoietic progenitors via mechanisms involving MIP-1α, J. Clin. Invest, 96, 931–939.
   PubMed Web of Science ®Google Scholar
• Gordon, M. Y., Dowdling, C. R., Riley, G. P., Goldman, J. M. and Greaves, M. F. (1984). Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukaemia, Nature, 328, 342–344.
   Web of Science ®Google Scholar
• Lundell, B. I., McCarthy, J. B., Kovach, N. L. and Verfaillie, C. M. (1996). Adhesion to fibronectin (FN) induced by the activating anti-integrin-β1 antibody, 8A2, restores adhesion mediated inhibition of CML progenitor proliferation, Blood, 87, 2450–2458.
   PubMed Web of Science ®Google Scholar
• Bhatia, R., McCarthy, J. B. and Verfaillie, C. M. (1996). Interferon-α restores normal β1 -integrin mediated negative regulation of chronic myelogenous leukemia progenitor proliferation, Blood, 87, 3883–3891.
   PubMed Web of Science ®Google Scholar
• Eaves, A. C., Cashman, J. D., Gaboury, L. A., Kalousek, D. K. and Eaves, C. J. (1986). Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells, Proc. Natl. Acad. Sci. USA, 83, 5306–10.
   PubMed Web of Science ®Google Scholar
• Ghaffari, S., Dougherty, G. J., Lansdorp, P. M., Eaves, A. C. and Eaves, J. C. (1995). Differentiation associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia, Blood, 86, 2976–2985.
   PubMed Web of Science ®Google Scholar
• Kovach, N. L., Carlos, T. M. Yee, E. and Harlan. J. M. (1992). A monoclonal antibody to β1 integrin (CD29) stimulates VLA-dependent adhesion of leukocytes to human umbilical vein endothelial cells and matrix components, J. Cell Biol, 116, 499–509.
   PubMed Web of Science ®Google Scholar
• Faull, R. J., Kovach, N. L. Harlan, J. M. and Ginsberg. M. H. (1994). Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: Two mechanisms with divergent biological consequences, J. Exp. Med, 179, 1307–1316.
   PubMed Web of Science ®Google Scholar
• Phillips, D. R., Charo, I. F. and Scarborough, R. M. (1991). GPIIb-IIIa: the responsive integrin, Cell, 65, 359–362.
   PubMed Web of Science ®Google Scholar
• Coller, B. S. (1986). Activation affects access to the platelet receptor for adhesive glycoproteins, J. Cell Biol, 103, 451–456.
   PubMed Web of Science ®Google Scholar
• Sànchez-Madrid, F. and Corbí, A. L. (1992). Leukocyte integrins: structure, function and regulation of their activity, Seminars in Cell Biol, 3, 199–210.
   PubMedGoogle Scholar
• Levesque, J. P., Leavesley, D. I., Niutta, S., Vadas, M. and Simmons, P. J. (1995). Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins, J. Exp. Med, 181, 1805–15.
   PubMed Web of Science ®Google Scholar
• Kovach, N. L., Lin, N., Yednock, T., Harlan, J. M. and Broudy, V. C. (1995). Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines, Blood, 85, 159–67.
   PubMed Web of Science ®Google Scholar
• Aneskievich, B. J., Haimovich, B. and Boettiger, D. (1991). Phosphorylation of integrin in differentiating ts-Rous sarcoma virus-infected myogenic cells, Oncogene, 6, 1381–90.
   PubMed Web of Science ®Google Scholar
• Johansson, M. W., Larsson, E., Luning, B., Pasquale, A. B. and Ruoslahti, E. (1994). Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated β1 Integrin, J. Cell Biol, 126, 1299–309.
   PubMed Web of Science ®Google Scholar
• Renshaw, M. W., McWhirter, J. R. and Wang, J. Y. (1995). The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation, Mole. & Cell, Biology, 15, 1286–93.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., Gishizky, M. L., Havlik, M. H. and Witte, O. N. (1993). SH1 domain autophosphorylation of p210 bcr/abl is required for transformation but not growth factor independence, Mol Cell Biol, 13, 1728–32.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., Muller, A.J., Havlik, M. H., Maru, Y. and Witte, O. N. (1991). BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner, Cell, 66, 161–71.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., LA Quilliam, Cripe, L. D. Bassing, C. H., Dai, Z., Li N. Batzer, A., Rabun, K. M., Der, C. J. and Schlessinger, J. (1993). BCR-ABL-Induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein, Cell, 75, 175–85.
   PubMed Web of Science ®Google Scholar
• Sawyers, C. L., McLaughlin, J. and Witte, O. N. (1995). Genetic requirement for RAS in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene, J Exp Med., 181, 307–313.
   PubMed Web of Science ®Google Scholar
• Oda, T., Heaney, C., Hagopian, J. R., Okuda, K., Griffin, J. D. and Druker, B. J. (1994). Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia, J. Biol. Chem, 269, 22925–8.
   PubMed Web of Science ®Google Scholar
• de Jong, R., ten Hoeve, J., Heisterkamp, N. and Groffen, J. (1995). Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia, J. Biol. Chem, 270, 21468–71.
   PubMed Web of Science ®Google Scholar
• Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K. and Silvennoinen, O. (1995). Signaling through the hematopoietic cytokine receptors, Annual Review of Immunology, 13, 369–98.
   PubMed Web of Science ®Google Scholar
• Hirano, T., Matsuda, T. and Nakajima, K. (1994). Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily, Stem Cells, 12, 262–77.
   PubMed Web of Science ®Google Scholar
• Salgia, R., Li, J. L., Lo, S. H., Brunkhorst, B., Kansas, G. S. Sobhany, E. S. Sun, Y., Pisick, E., Hallek, M. and Ernst, T. (1995). Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL, J. Biol. Chem, 270, 5039–47.
   PubMed Web of Science ®Google Scholar
• Van Etten, R. A., Jackson, P. K., Baltimore, D., Sanders, M. C., Matsudaira, P. T. and Janmey, P. A. (1994). The COOH-terminus of the c-abl tyrosine kinase contains distinct F-actin and G-acting binding domains with bundling activity, J. Cell. Biol, 124, 325–40.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R. and Wang, J. Y. (1993). An actin-binding function contributes to transformation by the bcr/abl oncoprotein in Philadelphia chromosome positive human leukemias, EMBO J, 12, 1533–46.
   PubMed Web of Science ®Google Scholar
• Prosper, F., Stronceck, D. and Verfaillie, C. M. (1996). Phenotypic And Functional Characterization Of Long-Term Culture Initiating Cells (LTC-IC) Present In Peripheral Blood Progenitor Collections Of Normal Donors Treated With G-CSF, Blood, 88, 2033–2042.
   PubMed Web of Science ®Google Scholar
• Sutherland, H. J., Eaves, C. J., Lansdorp, P. M., Phillips, G. L. and Hogge, D. E. (1994). Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants, Blood, 83, 3808–14.
   PubMed Web of Science ®Google Scholar
• Vose, J. M. and Armitage, J. O. (1995). Clinical applications of hematopoietic growth factors, J. of Clin. Oncol, 13, 1023–35.
   PubMed Web of Science ®Google Scholar
• Scheding, S., Brugger, W., Mertelsmann, R. and Kanz, L. (1994). Peripheral blood stem cells: in vivo biology and therapeutic potential, Stem Cells, 12 Suppl, 1, 203–10.
   Google Scholar
• Dercksen, M. W., Gerritsen, W. R., Rodenhuis, S., Dirkson, M. K., Slaper-Cortenbach, I. C., Schaasberg, W. P. Pinedo, H. M., von dem Borne, A. E. and van der Schoot, C. E. (1995). Expression of adhesion molecules on CD34+ cells: CD34 + L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation, Blood, 85, 3313–9.
   PubMed Web of Science ®Google Scholar
• Turner, M. L., McIlwaine, K., Anthony, R. S. and Parker, A. C. (1995). Differential expression of cell adhesion molecules by human hematopoietic progenitor cells from bone marrow and mobilized adult peripheral blood, Stem Cells, 13, 311–6.
   PubMed Web of Science ®Google Scholar
• Mohle, R., Murea, S., Kirsch, M. and Haas, R. (1995). Differential expression of L-selectin, VLA-4. and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery, Exp Hemat, 23, 1535–42.
   PubMed Web of Science ®Google Scholar
• Roberts, A. W. and Metcalf, D. (1995). State of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines, Blood, 86, 1600–5.
   PubMed Web of Science ®Google Scholar
• Ponchio, L., Conneally, E. and Eaves, C. (1995). Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro, Blood, 86, 3314–21.
   PubMed Web of Science ®Google Scholar